Immunemodulation in Patients With Minor Head Injury

The purpose of this study is to try to prove the worth of the two (2) Serum Proteins S-100 Beta and NSE in combination with a diagnostic algorithm to help to establish diagnosis in patients with minor head injury.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Head Trauma Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Craniocerebral Trauma Hemorrhage Intracranial Hemorrhages Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Trauma, Nervous System Vascular Diseases Wounds and Injuries

Age range

1 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Vienna

Vienna, State of Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

minor head injury

Exclusion criteria

severe head injury

Treatment and study plan

Primary outcomes

Intracranial Haematoma

Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Diagnostic Algorithm in Minor Head Injury

Acronym: MHI

Important dates

Study start: 2007
Primary completion: 2011
Study completion: 2011
First posted: Feb 25, 2008
Registry last updated: Apr 11, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed